Essential Psychopharmacology, 2014
Carl Salzman, MD
An updated review of clinical psychopharmacology will be presented. Neurobiology and pharmacokinetics and pharmacodynamics will be incorporated throughout the course, as well as careful analyses of clinical trials and their results. Specific clinical conditions examined will include schizophrenia, bipolar disorder, depressive illnesses, anxiety conditions, and personality disorders. Treatment will focus on adult patients, with specific discussion of medications for the elderly. Educational formats will include lectures, Q&A and cased based group discussions, which will engage the learners in the educational process.
• Evaluate the tenets of psychotropic drug treatment, with particular emphasis on recent advances and practical prescribing information;
• Review the basic tenets of the pharmacology of the major psychotropic drug classes;
• Review basic neurobiology as it relates to clinical practice with drug treatment;
• Describe the basic pharmacodynamics and pharmacokinetics of major drug classes;
• Implement clinical practice with antipsychotics based on the best randomized clinical trials for schizophrenia, bipolar disorder and depression;
• Determine when to use mood stabilizers and antidepressants based on the best randomized clinical trials for bipolar disorder and depression;
• Determine when to implement medical switch versus augmentation strategies for treatment-resistant depression;
• Make dosage adjustments in the elderly and for age, drug interactions, and sensitivity to side effects;
• Analyze the mechanisms, efficacy, and side effects of benzodiazepines for anxiety conditions and insomnia;
• Evaluate the inter play between pharmacologic and non-pharmacologic treatments.
Warning: Invalid argument supplied for foreach() in /nfs/c10/h13/mnt/150145/domains/continuingeducationprogram.org/html/wp-content/themes/bidmc/single-courses.php on line 110
Beth Israel Deaconess Department of Psychiatry Foundation, Inc./Contact Hours: 10
Physicians: The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Harvard Medical School designates this live activity for a maximum of 15 AMA PRA Category 1 Credits™. Physicians should claim only the credit ommensurate with the extent of their participation in the activity. Week-long Seminar: A maximum of 15 AMA PRA Category 1 Credits™ Weekend Seminar: A maximum of 10 AMA PRA Category 1 Credits™
Psychologists: The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School is approved by the American Psychological Association to offer continuing education for psychologists.
The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School maintains responsibility for this program and its content. Counselors: The Continuing Education Program at Beth Israel Deaconess Medical Center, a major teaching hospital of Harvard Medical School continuing education is an NBCC Approved Continuing Provider (ACEP) and may offer NBCC approved clock hours for events that meet NBCC requirements. The Week-Long Summer Seminars for a maximum of 15 clock hours and the Weekend Summer Seminars for a maximum of 10 clock hours. The ACEP solely is responsible for all aspects of the program.
Social Workers: For information on the status of the application to the Massachusetts Chapter of the National Association of Social Workers, please call 617-754-1265 or email: firstname.lastname@example.org License and Marriage Family Therapists: For information on the status of application to the Massachusetts Association for Marriage and Family Therapists, please call Stacy Ruiz at 617-754-1265 or email email@example.com.
Educators: For information of the status of application to the Commonwealth of assachusetts to offer Professional Development Points (PDSs), please call Stacy Ruiz at 617-754-1265 or emails firstname.lastname@example.org.
Nurses: Application has been made to the Massachusetts Association for Registered Nurses (MARN) for approval to award contact hours. MARN is accredited as an pprover of continuing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Carl Salzman MD is a Professor of Psychiatry, Harvard Medical School. He has served as Chairman, American Psychiatric Association Benzodiazepine Task Force. He has been awarded the Elvin V. Semrad Award for Outstanding Teaching in Psychiatry at the Massachusetts Mental Health Center, Vestermark Award from the American Psychiatric Association for Outstanding Contribution to Psychiatric Education, Heinz E. Lehmann Award from the New York State Department of Mental Hygiene for his contribution to psychiatric research, Teacher of the Year Award from CME and Outstanding Psychiatrist of the Year for Education by the Massachusetts Psychiatric Society. He has also been on numerous editorial boards including The American Journal of Psychiatry. Dr. Salzman is author of over 300 publications and 7 books. His latest book is Clinical Geriatric Psychopharmacology, 4th edition.